|Year||Cash distribution per share (in CHF)||Ex-date||Payment date|
Based on the notifications received by the Company, the following shareholders reported equity holdings in HBM Healthcare Investments Ltd of three percent or more as at 31 March 2019:
|15 - 20%||Nogra Pharma Invest S.à.r.l., Luxemburg|
See here for details about significant shareholders in HBM Healthcare Investments Ltd. (SIX Swiss Exchange).
Management fees (paid quarterly):
0.75% of company assets plus
0.75% of the company's market capitalisation
Performance fee (paid annually):
15% on increase in value above the high water mark. High water mark (per share for all outstanding shares) for financial year 2019/2020: NAV of CHF 194.36.
See here for details about Management transactions in HBM Healthcare Investments' shares (SIX Swiss Exchange).
Articles of association
Share buy-back programmes
Share buy-back programme 2019
The maximum permissible daily repurchase volume in accordance with Art. 123 para. 1 lit. (c) FinfraV amounts to 1'203 shares.
Share buy-back programme 2016 (completed)
The maximum permissible daily repurchase volume in accordance with Art. 123 para. 1 lit. (c) FinfraV amounts to 2'389 shares.